机构名称：
¥ 9.0
卢森堡的大型杜奇（Div）通过常规指标的监测以及特定的研究项目和评估来评估其药物政策和策略。An external mixed-methods evaluation of the 4 th National Drug Strategy and Action Plan was conducted by the Trimbos Institute of the Netherlands in 2019, showing that the majority of the objectives outlined in the 2015-2019 action plan were met and proven to be effective, recommending to pursue the adopted approach and underlying principles of evidence-based policies, with a balanced approach and focus on health and human rights (Kools, van der Gouwe ＆Strada，2019年）。外部评估的建议有助于阐述当前2020 - 2024年国家药物战略和行动计划。2020-2024国家药物战略和行动计划是横向和多维的，而其详细说明还涉及来自国家和国际层面不同领域的利益相关者和专家。
国家药物报告2022
主要关键词
相关文件推荐
